NCT01094821View on ClinicalTrials.gov

Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Healthy
Interventions
DRUG

ATI-7505

3 mg three times daily for 9 days

DRUG

Placebo

Placebo capsule three times daily for 9 days

DRUG

ATI-7505

10 mg ATI-7505 three times daily for 9 days

DRUG

ATI-7505

20 mg ATI-7505 three times daily for 9 days

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

ARYx Therapeutics
All Listed Sponsors
collaborator

ARYx Therapeutics

INDUSTRY

lead

Mayo Clinic

OTHER